Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
Murakami M, Nakamura K, Kusano KF, Morita H, Nakagawa K, Tanaka M, Tada T, Toh N, Nishii N, Nagase S, Hata Y, Kohno K, Miura D, Ohe T, Ito H. Murakami M, et al. Among authors: hata y. J Cardiovasc Pharmacol. 2010 Oct;56(4):389-95. doi: 10.1097/FJC.0b013e3181f03c2f. J Cardiovasc Pharmacol. 2010. PMID: 20625312 Clinical Trial.
Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
Tanaka M, Nakamura K, Kusano KF, Morita H, Ohta-Ogo K, Miura D, Miura A, Nakagawa K, Tada T, Murakami M, Nishii N, Nagase S, Hata Y, Kohno K, Ouchida M, Shimizu K, Yutani C, Ohe T, Ito H. Tanaka M, et al. Among authors: hata y. Cardiovasc Pathol. 2011 Jan-Feb;20(1):e37-42. doi: 10.1016/j.carpath.2010.02.002. Epub 2010 Mar 12. Cardiovasc Pathol. 2011. PMID: 20219395
Anti-tachycardia pacing degenerated fast ventricular tachycardia into undetectable life-threatening tachyarrhythmia in a patient with non-ischemic dilated cardiomyopathy.
Yunoki K, Nishii N, Morita H, Iwasaki J, Nagase S, Nakamura K, Hata Y, Kohno K, Kusano KF, Ito H. Yunoki K, et al. Among authors: hata y. J Cardiol Cases. 2010 Aug 8;2(3):e159-e162. doi: 10.1016/j.jccase.2010.06.003. eCollection 2010 Dec. J Cardiol Cases. 2010. PMID: 30546708 Free PMC article.
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus.
Ejiri K, Miyoshi T, Kihara H, Hata Y, Nagano T, Takaishi A, Toda H, Nanba S, Nakamura Y, Akagi S, Sakuragi S, Minagawa T, Kawai Y, Nishii N, Fuke S, Yoshikawa M, Nakamura K, Ito H; MUSCAT‐HF Study Investigators †. Ejiri K, et al. Among authors: hata y. J Am Heart Assoc. 2020 Aug 18;9(16):e015103. doi: 10.1161/JAHA.119.015103. Epub 2020 Aug 1. J Am Heart Assoc. 2020. PMID: 32805185 Free PMC article. Clinical Trial.
Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction.
Nakashima M, Miyoshi T, Ejiri K, Kihara H, Hata Y, Nagano T, Takaishi A, Toda H, Nanba S, Nakamura Y, Akagi S, Sakuragi S, Minagawa T, Kawai Y, Nishii N, Fuke S, Yoshikawa M, Nakamura K, Ito H; MUSCAT‐HF Study Investigators. Nakashima M, et al. Among authors: hata y. ESC Heart Fail. 2022 Feb;9(1):712-720. doi: 10.1002/ehf2.13683. Epub 2021 Nov 3. ESC Heart Fail. 2022. PMID: 35267246 Free PMC article. Clinical Trial.
1,509 results